Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OT329 Solis vs Advair Diskus in Asthma
NCT02260492Phase 1Completed
- Sponsor
- Oriel Therapeutics, Inc.
- Start
- Sep 2014
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of OT-82 in asthma, sponsored by Oriel Therapeutics, Inc. Started Sep 2014; status: completed.
02
Drugs
OT-82
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02260492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260492.